NCT00290147View on ClinicalTrials.gov

Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

April 30, 2009

Conditions
Dengue
Interventions
BIOLOGICAL

D1ME100 (dengue-1 premembrane/envelope DNA vaccine)

IM injection delivered by Biojector

Trial Locations (1)

20910

Walter Reed Army Institute of Research, Bldg 503, Silver Spring

All Listed Sponsors
collaborator

United States Army Medical Materiel Development Activity

FED

lead

U.S. Army Medical Research and Development Command

FED

NCT00290147 - Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine | Biotech Hunter | Biotech Hunter